1. Home
  2. NRIM vs VNDA Comparison

NRIM vs VNDA Comparison

Compare NRIM & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NRIM

Northrim BanCorp Inc

N/A

Current Price

$24.54

Market Cap

602.6M

Sector

Finance

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$4.81

Market Cap

301.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRIM
VNDA
Founded
1990
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.6M
301.1M
IPO Year
2002
2005

Fundamental Metrics

Financial Performance
Metric
NRIM
VNDA
Price
$24.54
$4.81
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
★ $30.33
$11.75
AVG Volume (30 Days)
117.8K
★ 598.5K
Earning Date
10-21-2026
10-28-2026
Dividend Yield
★ 2.81%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.29
N/A
Revenue
★ $255,581,000.00
$216,105,000.00
Revenue This Year
$1.17
$15.16
Revenue Next Year
$26.82
$35.50
P/E Ratio
$18.82
★ N/A
Revenue Growth
★ 30.43
8.72
52 Week Low
$19.60
$4.27
52 Week High
$30.82
$9.91

Technical Indicators

Market Signals
Indicator
NRIM
VNDA
Relative Strength Index (RSI) 28.92 39.46
Support Level $23.72 $4.45
Resistance Level $25.45 $5.37
Average True Range (ATR) 0.55 0.16
MACD -0.11 -0.01
Stochastic Oscillator 7.72 8.16

Price Performance

Historical Comparison
NRIM
VNDA

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: